ArticleWorld journal of urology2025
Applications, benefits, and challenges of adopting teleurology: a scoping review.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrological diseases present substantial challenges for patients, including restricted access to specialized care, prolonged wait times, and geographical barriers, particularly in underserved and rural regions. Teleurology leverages telecommunication technologies to enable remote consultations, improve patient monitoring, and enhance access to specialized care. This scoping review aims to systematically examine the applications, benefits, and challenges associated with teleurology, offering a comprehensive analysis of its role in contemporary urological practice.
methodsThe PRISMA-ScR guidelines was followed to perform this scoping review. Systematic searches were performed in PubMed, Scopus, and Web of Science, covering publications from 2010 until January 19, 2025. Two trained reviewers independently retrieved, screened, and extracted the data.
resultsThe initial search identified 2,080 studies. After removing 500 duplicates, 1,577 unique studies remained for title and abstract screening. Ultimately, 49 articles were selected for data extraction. The most frequent teleurology communication interventions were Telephone (n = 12) and Videoconferencing (n = 11). Teleurology services were predominantly delivered through synchronous modalities (77%), followed by a combination of synchronous and asynchronous approaches (18%). Tele-consultation (n = 18), Tele-visit (n = 15), and Tele-care, in that order (n = 8) were the most common applications. A total of 339 benefits (n = 216) and challenges (n = 123) for teleurology were identified, with 28 benefits and 13 challenges remaining after consolidation. "Reducing patient treatment expenditures, travel costs and time" (n = 30), "Increasing patient satisfaction with telemedicine services" (n = 23), "Access to care for patients in rural or underserved areas" (n = 17), and "Curbing disease spread and sustaining care during pandemics while maintaining distancing" (n = 17) were the most common benefits of teleurology. The most important challenges were "Lack of physical examination of patients during telemedicine visits" (n = 30), "Need for robust digital infrastructure (inaccessible to technology, computer and internet)" (n = 23), and "Patient concerns about confidentiality and privacy" (n = 18).
conclusionsTeleurology improves access, reduces costs, and enhances patient satisfaction, especially in underserved areas. However, physical exam limitations, infrastructure gaps, and privacy concerns remain challenges. Future efforts should refine teleurology frameworks and strengthen digital infrastructure for secure, high-quality care.
Indexed as
Identifiers
40423718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.